IPO GMP race: Jio Platforms initial public offering (IPO) witnessed robust demand on Day 1, garnering 3.04 times subscription on Wednesday, October 21. Its latest grey market premium today (GMP) indicated potential listing gains of around 22%.
In contrast, Paras Healthcare, which also opened for subscription on the same day, saw a muted response, with its GMP pointing to estimated listing gains of 5.05%. For primary market investors, here is a complete comparison of Reliance Jio IPO GMP and Paras Healthcare IPO GMP.
Mukesh Ambani’s Reliance Industries Limited (RIL)-backed Jio Platforms’s IPO GMP stood at ₹249. Considering its grey market premium and upper price band, the Jio IPO is likely to be listed at ₹1368 per share (which is the sum of IPO GMP and upper price band), which hints at 22.25% of expected listing gain.
Paras Healthcare IPO grey market premium (GMP) was recorded at ₹30, as per media reports at 8 pm on October 21. With an upper price band of ₹693, the estimated listing price for Paras Healthcare IPO is ₹723 (which is the sum of upper price band and latest grey market premium). The IPO is expected to be listed with 4.33% gain.
Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.